WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Stock Ownership - Who owns Akebia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akebia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard C. MalabreSVP Chief Accounting Officer2025-06-0915,000$4.01
$60.15kSell
Richard C. MalabreSVP Chief Accounting Officer2025-06-0915,000$1.68
$25.20kBuy
Richard C. MalabreSVP Chief Accounting Officer2025-06-0413,334$3.53
$47.07kSell
Steven Keith BurkeSVP Chief Medical Officer2025-03-037,144$1.83
$13.07kSell
John P. ButlerCEO and President2025-03-0346,409$1.83
$84.93kSell
Richard C. MalabreSVP Chief Accounting Officer2025-02-0330,202$2.10
$63.42kSell
Steven Keith BurkeSVP Chief Medical Officer2025-02-0323,270$2.10
$48.87kSell
Steven Keith BurkeSVP Chief Medical Officer2025-02-0327,236$2.10
$57.20kSell
John P. ButlerCEO and President2025-02-0346,268$2.10
$97.16kSell
John P. ButlerCEO and President2025-02-0397,982$2.10
$205.76kSell

1 of 2

AKBA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKBA insiders and whales buy or sell their stock.

AKBA Shareholders

What type of owners hold Akebia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc5.84%15,332,163$54.58MInstitution
Vanguard Group Inc4.83%12,685,803$45.16MInstitution
State Street Corp2.59%6,805,807$24.23MInstitution
Muneer A. Satter1.92%5,039,602$17.94MInsider
Geode Capital Management LLC1.92%5,030,740$17.91MInstitution
Great Point Partners LLC1.89%4,973,840$17.71MInstitution
Renaissance Technologies LLC1.53%4,005,827$14.26MInstitution
Citadel Advisors LLC1.39%3,646,909$12.98MInstitution
John P. Butler1.32%3,455,421$12.30MInsider
Novartis Bioventures Ltd1.30%3,405,764$12.12MInsider

1 of 3

AKBA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKBA36.36%7.74%Net SellingNet Selling
MLYS61.12%38.88%Net BuyingNet Selling
ABCL41.78%44.65%Net Buying
PHVS82.47%0.00%
NRIX90.94%9.06%Net SellingNet Selling
View Top Biotech Stocks

Akebia Therapeutics Stock Ownership FAQ

Who owns Akebia Therapeutics?

Akebia Therapeutics (NASDAQ: AKBA) is owned by 36.36% institutional shareholders, 7.74% Akebia Therapeutics insiders, and 55.90% retail investors. Muneer A. Satter is the largest individual Akebia Therapeutics shareholder, owning 5.04M shares representing 1.92% of the company. Muneer A. Satter's Akebia Therapeutics shares are currently valued at $17.94M.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.